BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Dr Reddy’s to Invest INR 700 Cr in Biosimilars & API Capacity Expansion January 16, 2024 Dr Reddy's investment plan involves expansion in biologics and other divisions, pushing the total yearly capital expenditure to around INR 1,400 Cr.
Dr Reddy's Launches USFDA-Approved Wearable ‘Nerivio’ for Migraine Management in India November 17, 2023 Patients can use the device within 60 minutes of the onset of a headache for acute migraine treatment or every alternate day for migraine prevention.
Page 1 of 1
